BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36731371)

  • 1. Key regulators in the architecture of substrate access/egress channels in mammalian cytochromes P450 governing flexibility in substrate oxyfunctionalization.
    Hlavica P
    J Inorg Biochem; 2023 Apr; 241():112150. PubMed ID: 36731371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in assignment of allosteric effects in cytochrome P450-catalyzed substrate oxidations to structural dynamics in the hemoprotein architecture.
    Hlavica P
    J Inorg Biochem; 2017 Feb; 167():100-115. PubMed ID: 27919007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative biotransformation of fatty acids by cytochromes P450: predicted key structural elements orchestrating substrate specificity, regioselectivity and catalytic efficiency.
    Hlavica P; Lehnerer M
    Curr Drug Metab; 2010 Jan; 11(1):85-104. PubMed ID: 20302567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interaction of nitrogenous organic bases with cytochrome P450: a critical assessment and update of substrate features and predicted key active-site elements steering the access, binding, and orientation of amines.
    Hlavica P
    Biochim Biophys Acta; 2006 Apr; 1764(4):645-70. PubMed ID: 16503427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insect cytochromes P450: topology of structural elements predicted to govern catalytic versatility.
    Hlavica P
    J Inorg Biochem; 2011 Oct; 105(10):1354-64. PubMed ID: 21930014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of structural features in fungal cytochromes P450 predicted to rule catalytic diversification.
    Hlavica P
    Biochim Biophys Acta; 2013 Jan; 1834(1):205-20. PubMed ID: 23009807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do mammalian cytochrome P450s show multiple ligand access pathways and ligand channelling?
    Schleinkofer K; Sudarko ; Winn PJ; Lüdemann SK; Wade RC
    EMBO Rep; 2005 Jun; 6(6):584-9. PubMed ID: 16028306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational states of cytochrome P450cam revealed by trapping of synthetic molecular wires.
    Hays AM; Dunn AR; Chiu R; Gray HB; Stout CD; Goodin DB
    J Mol Biol; 2004 Nov; 344(2):455-69. PubMed ID: 15522298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanodisc-embedded cytochrome P450 P3A4 binds diverse ligands by distributing conformational dynamics to its flexible elements.
    Paço L; Hackett JC; Atkins WM
    J Inorg Biochem; 2023 Jul; 244():112211. PubMed ID: 37080138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a relationship between the substrate preferences and structural flexibility of cytochromes P450?
    Otyepka M; Berka K; Anzenbacher P
    Curr Drug Metab; 2012 Feb; 13(2):130-42. PubMed ID: 22208528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cytochrome P450 enzymes bind drugs and other substrates mainly through conformational-selection modes.
    Guengerich FP; Wilkey CJ; Phan TTN
    J Biol Chem; 2019 Jul; 294(28):10928-10941. PubMed ID: 31147443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flexibility of human cytochrome P450 enzymes: molecular dynamics and spectroscopy reveal important function-related variations.
    Hendrychová T; Anzenbacherová E; Hudeček J; Skopalík J; Lange R; Hildebrandt P; Otyepka M; Anzenbacher P
    Biochim Biophys Acta; 2011 Jan; 1814(1):58-68. PubMed ID: 20656072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational diversity and ligand tunnels of mammalian cytochrome P450s.
    Yu X; Cojocaru V; Wade RC
    Biotechnol Appl Biochem; 2013; 60(1):134-45. PubMed ID: 23587001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural differences between soluble and membrane bound cytochrome P450s.
    Denisov IG; Shih AY; Sligar SG
    J Inorg Biochem; 2012 Mar; 108():150-8. PubMed ID: 22244217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational adaptation of human cytochrome P450 2B6 and rabbit cytochrome P450 2B4 revealed upon binding multiple amlodipine molecules.
    Shah MB; Wilderman PR; Pascual J; Zhang Q; Stout CD; Halpert JR
    Biochemistry; 2012 Sep; 51(37):7225-38. PubMed ID: 22909231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions.
    Tang W; Stearns RA
    Curr Drug Metab; 2001 Jun; 2(2):185-98. PubMed ID: 11469725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural flexibility and functional versatility of cytochrome P450 and rapid evolution.
    Negishi M; Iwasaki M; Juvonen RO; Sueyoshi T; Darden TA; Pedersen LG
    Mutat Res; 1996 Feb; 350(1):43-50. PubMed ID: 8657195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing possible egress channels for multiple ligands in human CYP3A4: a molecular modeling study.
    Krishnamoorthy N; Gajendrarao P; Thangapandian S; Lee Y; Lee KW
    J Mol Model; 2010 Apr; 16(4):607-14. PubMed ID: 19727863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Including ligand-induced protein flexibility into protein tunnel prediction.
    Kingsley LJ; Lill MA
    J Comput Chem; 2014 Sep; 35(24):1748-56. PubMed ID: 25043499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Enzyme Flexibility in Ligand Access and Egress to Active Site: Bias-Exchange Metadynamics Study of 1,3,7-Trimethyluric Acid in Cytochrome P450 3A4.
    Paloncýová M; Navrátilová V; Berka K; Laio A; Otyepka M
    J Chem Theory Comput; 2016 Apr; 12(4):2101-9. PubMed ID: 26967371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.